X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospectrumasia.com/news/25/24208/rbobay-pharma-boosts-crdmo-offerings-with-cytivas-flexfactory-platform.html
https://www.indianpharmapost.com/news/asahi-kasei-bioprocess-and-axolabs-partner-to-accelerate-oligonucleotide-therapeutics-development-15509
https://www.bachem.com/news/elena-zakharova-wins-cancer-drug-discovery-research-award/
https://www.contractpharma.com/contents/view_breaking-news/2023-08-30/intellegens-cpi-awarded-innovate-uk-grant-for-oligonucleotide-therapeutics/
https://www.euroapi.com/en/EUROAPI-to-acquire-BianoGMP-to-strengthen-its-CDMO-expertise-in-the-high-growth-oligonucleotide-market
https://www.fiercebiotech.com/biotech/fda-blocks-pepgens-attempt-get-second-oligonucleotide-clinic
https://www.biospace.com/article/releases/pepgen-inc-announces-clinical-hold-in-the-u-s-on-ind-application-to-initiate-a-phase-1-study-of-pgn-edodm1-for-myotonic-dystrophy-type-1-dm1-/
https://www.bachem.com/news/purification-a-bottleneck-for-large-scale-manufacturing-of-oligonucleotide-api/
https://www.prnewswire.com/news-releases/avidity-biosciences-receives-fda-orphan-drug-designation-for-aoc-1020-for-the-treatment-of-facioscapulohumeral-muscular-dystrophy-301745952.html
https://www.bachem.com/news/new-mass-spectrometry-characterization-for-an-accurate-identification-of-oligonucleotide-impurities/
https://endpts.com/biospring-invests-e100m-into-new-oligonucleotide-based-api-facilities-in-germany/
https://www.clinicaltrialsarena.com/news/splisense-trial-spl84-cystic-fibrosis/
https://www.biospace.com/article/gsk-strikes-3-3b-oligonucleotide-pact-with-wave-life-sciences/
https://www.europeanpharmaceuticalreview.com/news/176217/oligonucleotide-helps-prevent-chronic-hepatitis-b/
https://www.chemanager-online.com/en/news/bachem-innovates-its-manufacturing-capabilities
https://www.bachem.com/news/our-key-ingredients-for-a-successful-oligonucleotide-drug-development/
https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-positive-topline-safety-and-pharmacokinetic-pk-data-from-the-phase-1-single-ascending-dose-sad-clinical-trial-of-rgls8429-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-301621359.html
https://www.bachem.com/news/innovation-transforming-oligonucleotide-manufacturing/
https://www.contractpharma.com/contents/view_breaking-news/2021-11-29/st-pharm-to-expand-oligonucleotide-facility/?widget=listSection
https://www.fiercebiotech.com/biotech/ionis-pays-bicycle-45m-to-expand-oligonucleotide-delivery-toolkit
https://www.contractpharma.com/contents/view_breaking-news/2021-03-26/asymchem-expands-oligonucleotides-mfg-capacity/?widget=listSection
https://www.globenewswire.com/news-release/2020/09/29/2100905/0/en/OliX-Pharmaceuticals-to-Present-New-Data-in-Liver-and-Ophthalmic-Areas-at-16th-Annual-Meeting-of-the-Oligonucleotide-Therapeutics-Society-OTS.html
https://pharmaphorum.com/partner-content/innovate-uk-funding-for-new-precision-cancer-treatment-technology/
https://www.globenewswire.com/news-release/2020/08/18/2080093/0/en/Aligos-Therapeutics-Doses-First-Subject-in-Phase-1-Proof-of-Concept-Study-of-Oligonucleotide-Drug-Candidate-ALG-010133.html
https://www.biospectrumasia.com/news/28/15183/wuxi-sta-opens-oligonucleotide-large-scale-manufacturing-facility.html
https://www.pharmacompass.com/pdf/news/cordenpharma-announces-commercial-oligonucleotide-api-manufacturing-expansion-in-cordenpharma-colorado-1525235106.pdf
https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-present-data-als-and-ftd-programs-and
https://www.contractpharma.com/contents/view_breaking-news/2018-04-10/wave-life-sciences-deep-genomics-enter-collaboration/
https://www.prnewswire.com/news-releases/avecia-announces-opening-of-cambridge-ma-office-300591630.html
https://www.pharmacompass.com/pdf/news/cordenpharma-ge-healthcare-offer-unique-end-to-end-solution-to-accelerate-oligonucleotide-drug-development-1498724513.pdf
http://www.fiercepharma.com/manufacturing/agilent-will-double-oligonucleotides-capacity-a-new-colorado-plant
http://www.in-pharmatechnologist.com/Ingredients/Agilent-to-up-Oligo-API-capacity-with-new-manufacturing-plant
Market Place
Share 
